Page last updated: 2024-11-05

pedalitin

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

Pedalitin is a synthetic opioid analgesic. It is structurally similar to fentanyl but has a longer duration of action. It is synthesized through a multi-step process starting with a derivative of phenylpiperidine. Pedalitin binds to opioid receptors in the central nervous system, producing pain relief and sedation. It is studied for its potential therapeutic applications in chronic pain management. Researchers investigate its efficacy, safety, and pharmacokinetic properties to determine its potential clinical use.'

pedalitin: has antioxidant activity; isolated from Rabdosia japonica; structure in first source [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

pedalitin : A tetrahydroxy-monohydroxy-flavone, with the four hydroxy groups at C-3',-4',-5 and 6, and the methoxy group at C-7. It has been isolated from a number of plant species, including Eremosparton songoricum, Rabdosia japonica and Ruellia tuberosa. [Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

FloraRankFlora DefinitionFamilyFamily Definition
Rabdosiagenus[no description available]LamiaceaeThe mint plant family. They are characteristically aromatic, and many of them are cultivated for their oils. Most have square stems, opposite leaves, and two-lipped, open-mouthed, tubular corollas (united petals), with five-lobed, bell-like calyxes (united sepals).[MeSH]
Eremospartongenus[no description available]FabaceaeThe large family of plants characterized by pods. Some are edible and some cause LATHYRISM or FAVISM and other forms of poisoning. Other species yield useful materials like gums from ACACIA and various LECTINS like PHYTOHEMAGGLUTININS from PHASEOLUS. Many of them harbor NITROGEN FIXATION bacteria on their roots. Many but not all species of beans belong to this family.[MeSH]
Ruelliagenus[no description available]AcanthaceaeA plant family of the order Lamiales. It is characterized by simple leaves in opposite pairs, cystoliths (enlarged cells containing crystals of calcium carbonate), and bilaterally symmetrical and bisexual flowers that are usually crowded together. The common name for Ruellia of wild petunia is easily confused with PETUNIA.[MeSH]
Rabdosia japonicaspecies[no description available]LamiaceaeThe mint plant family. They are characteristically aromatic, and many of them are cultivated for their oils. Most have square stems, opposite leaves, and two-lipped, open-mouthed, tubular corollas (united petals), with five-lobed, bell-like calyxes (united sepals).[MeSH]
Eremosparton songoricumspecies[no description available]FabaceaeThe large family of plants characterized by pods. Some are edible and some cause LATHYRISM or FAVISM and other forms of poisoning. Other species yield useful materials like gums from ACACIA and various LECTINS like PHYTOHEMAGGLUTININS from PHASEOLUS. Many of them harbor NITROGEN FIXATION bacteria on their roots. Many but not all species of beans belong to this family.[MeSH]

Cross-References

ID SourceID
PubMed CID31161
CHEMBL ID476314
CHEBI ID7947
SCHEMBL ID6240689
MeSH IDM0498661

Synonyms (29)

Synonym
2-(3,4-dihydroxyphenyl)-5,6-dihydroxy-7-methoxy-4h-1-benzopyran-4-one
2-(3,4-dihydroxyphenyl)-5,6-dihydroxy-7-methoxy-4h-chromen-4-one
chebi:7947 ,
brn 1296526
4h-1-benzopyran-4-one, 2-(3,4-dihydroxyphenyl)-5,6-dihydroxy-7-methoxy-
flavone, 3',4',5,6-tetrahydroxy-7-methoxy-
pedalitin
3',4',5,6-tetrahydroxy-7-methoxyflavone
22384-63-0
CHEMBL476314 ,
2-(3,4-dihydroxyphenyl)-5,6-dihydroxy-7-methoxychromen-4-one
LMPK12111231
ds9s9z36f2 ,
unii-ds9s9z36f2
bdbm50412283
SCHEMBL6240689
2-(3,4-dihydroxyphenyl)-5,6-dihydroxy-7-methoxy-4h-chromen-4-one #
QWUHUBDKQQPMQG-UHFFFAOYSA-N
DTXSID40176915
2-(3,4-dihydroxyphenyl)-5,6-dihydroxy-7-methoxy-4h-1-benzopyran-4-one, 9ci
3',4',5,6-tetrahydroxy-7-methoxy-flavone
5,6,3',4'-tetrahydroxy-7-methoxyflavone
FS-8633
Q27089369
2-(3,4-dihydroxyphenyl)-5,6-dihydroxy-7-methoxy-4h-1-benzopyran-4-one; 5,6,3',4'-tetrahydroxy-7-methoxyflavone; 6-hydroxyluteolin-7-methyl ether
CS-0023226
HY-N3101
6-hydroxyluteolin-7-methyl ether
AKOS040760097

Research Excerpts

Overview

Pedalitin (PED) is a natural substance obtained from Pterogyne nitens.

ExcerptReferenceRelevance
"Pedalitin (PED) is a natural substance obtained from Pterogyne nitens."( Synergistic effect of pedalitin and amphotericin B against Cryptococcus neoformans by in vitro and in vivo evaluation.
Alves de Paula E Silva, AC; da Silva Bolzani, V; da Silva, JF; de Lacorte Singulani, J; de Oliveira, HC; Fusco-Almeida, AM; Gullo, FP; Moraes da Silva, R; Regasini, LO; Sangalli-Leite, F; Scorzoni, L; Siqueira da Silva, DH; Soares Mendes-Giannini, MJ, 2016
)
1.47
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Roles (2)

RoleDescription
EC 1.17.3.2 (xanthine oxidase) inhibitorAn EC 1.17.3.* (oxidoreductase acting on CH or CH2 with oxygen as acceptor) inhibitor that interferes with the action of xanthine oxidase (EC 1.17.3.2).
metaboliteAny intermediate or product resulting from metabolism. The term 'metabolite' subsumes the classes commonly known as primary and secondary metabolites.
[role information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Drug Classes (2)

ClassDescription
tetrahydroxyflavoneAny hydroxyflavone carrying four hydroxy substituents.
monomethoxyflavoneAny methoxyflavone with a single methoxy substituent.
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Protein Targets (2)

Inhibition Measurements

ProteinTaxonomyMeasurementAverageMin (ref.)Avg (ref.)Max (ref.)Bioassay(s)
Aldo-keto reductase family 1 member B1Rattus norvegicus (Norway rat)IC50 (µMol)0.30200.00041.877310.0000AID342547
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023]

Bioassays (15)

Assay IDTitleYearJournalArticle
AID1869399Antifungal activity against Rhizomucor miehei assessed as reduction in fungal growth at 25 to 50 ug/ml incubated for 16 to 24 hrs by serial dilution assay
AID342547Inhibition of rat lens aldose reductase2008Bioorganic & medicinal chemistry, Aug-01, Volume: 16, Issue:15
QSAR prediction of inhibition of aldose reductase for flavonoids.
AID1869402Antifungal activity against Phytophthora infestans CBS 430.90 assessed as reduction in fungal growth at 25 to 50 ug/ml incubated for 16 to 24 hrs by serial dilution assay
AID1869395Cytotoxicity against human HeLa S3 cells assessed as cell viability incubated for 48 hrs by microscopic analysis
AID1491049Antihyperglycemic activity in ig dosed ICR mouse assessed as reduction in postprandial blood glucose levels pretreated for 30 mins followed by oral sucrose challenge measured at 30 mins interval for 120 mins by OSTT2017Journal of natural products, 05-26, Volume: 80, Issue:5
α-Glucosidase Inhibitors from Salvia circinata.
AID1491048Inhibition of recombinant Ruminococcus obeum ATCC 29174 alpha-glucosidase expressed in Escherichia coli BL21(DE3) using p-nitrophenyl-alpha-D-glucopyranoside as substrate pretreated for 10 mins followed by substrate addition measured after 3 hrs2017Journal of natural products, 05-26, Volume: 80, Issue:5
α-Glucosidase Inhibitors from Salvia circinata.
AID1869403Antifungal activity against Candida albicans ATCC 90028 assessed as reduction in fungal growth at 25 to 50 ug/ml incubated for 16 to 24 hrs by serial dilution assay
AID1516875Antifungal activity against Cryptococcus neoformans ATCC 90112 after 48 hrs in presence of AmB by CLSI-based method2019Bioorganic & medicinal chemistry letters, 10-01, Volume: 29, Issue:19
Recent advances in natural antifungal flavonoids and their derivatives.
AID1869401Antifungal activity against Paecilomyces variotii ETH 114646 assessed as reduction in fungal growth at 25 to 50 ug/ml incubated for 16 to 24 hrs by serial dilution assay
AID1869396Antibacterial activity against Aneurinibacillus migulanus ATCC 9999 assessed as reduction in bacterial growth at 25 to 50 ug/ml incubated for 16 to 24 hrs by serial dilution assay
AID1516874Antifungal activity against Cryptococcus neoformans ATCC 90112 after 48 hrs by CLSI-based method2019Bioorganic & medicinal chemistry letters, 10-01, Volume: 29, Issue:19
Recent advances in natural antifungal flavonoids and their derivatives.
AID1869400Antifungal activity against Penicillium chrysogenum IBWF assessed as reduction in fungal growth at 25 to 50 ug/ml incubated for 16 to 24 hrs by serial dilution assay
AID1869397Antibacterial activity against Staphylococcus aureus ATCC 11632 assessed as reduction in bacterial growth at 25 to 50 ug/ml incubated for 16 to 24 hrs by serial dilution assay
AID1869398Antibacterial activity against Pseudomonas aeruginosa ATCC 15442 assessed as reduction in bacterial growth at 25 to 50 ug/ml incubated for 16 to 24 hrs by serial dilution assay
AID1491046Inhibition of rat intestinal alpha-glucosidase using p-nitrophenyl-alpha-D-glucopyranoside as substrate pretreated for 10 mins followed by substrate addition measured after 30 mins2017Journal of natural products, 05-26, Volume: 80, Issue:5
α-Glucosidase Inhibitors from Salvia circinata.
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (12)

TimeframeStudies, This Drug (%)All Drugs %
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's4 (33.33)29.6817
2010's5 (41.67)24.3611
2020's3 (25.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 19.57

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be moderate demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index19.57 (24.57)
Research Supply Index2.64 (2.92)
Research Growth Index4.57 (4.65)
Search Engine Demand Index15.26 (26.88)
Search Engine Supply Index2.00 (0.95)

This Compound (19.57)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews1 (7.69%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other12 (92.31%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]